F. Griesinger

发表

The MLL recombinome of acute leukemias

M. D. Boer, R. Pieters, R. Pieters, 2006, Leukemia.

Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer

H. Kauczor, I. Petersen, C. Rübe, 2010, Pneumologie.

T cell receptor gamma and delta rearrangements in hematologic malignancies. Relationship to lymphoid differentiation.

J. Kersey, F. Griesinger, J. Greenberg, 1989, The Journal of clinical investigation.

Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML

W. Hiddemann, T. Haferlach, S. Schnittger, 2000, Leukemia.

Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study.

C. Schumann, I. Zuna, M. Kreuter, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia

L. Klein-Hitpass, L. Trümper, J. Dürig, 2005, Leukemia.

Leukemia- and lymphoma-associated genetic aberrations in healthy individuals

L. Trümper, F. Griesinger, J. Bäsecke, 2002, Annals of Hematology.

Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study

K. Friedrichs, N. Harbeck, O. Gluz, 2019, Breast Cancer Research and Treatment.

Docetaxel-carboplatin chemotherapy combined with cetuximab in patients with locally advanced or metastatic non small-cell lung cancer (NSCLC)--results of the nonrandomised phase II study TaxErb.

F. Griesinger, J. Fischer, M. Wolf, 2012, Lung cancer.

Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors.

W. Hiddemann, S. Schnittger, B. Wörmann, 1998, Blood.

Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing.

M. Kriegsmann, P. Schirmacher, A. Stenzinger, 2020, Lung cancer.